Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study

OBJECTIVE: To determine if variations in trial eligibility criteria and patient baseline characteristics could be considered effect modifiers of the treatment response when testing targeted therapies (biological agents and targeted synthetic disease modifying antirheumatic drugs (DMARDs)) for rheuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Anton Wulf, Tarp, Simon, Furst, Daniel E., Døssing, Anna, Amris, Kirstine, Bliddal, Henning, Taylor, Peter C., Christensen, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567072/
https://www.ncbi.nlm.nih.gov/pubmed/26360583
http://dx.doi.org/10.1371/journal.pone.0136982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567072/
https://www.ncbi.nlm.nih.gov/pubmed/26360583
http://dx.doi.org/10.1371/journal.pone.0136982

Ejemplares similares